SALUTAS PHARMA GMBH — Furosemide Importer Profile
Pharmaceutical Importer · #5 buyer for Furosemide · $2.0M import value · 64 shipments · GERMANY · DGFT Verified
SALUTAS PHARMA GMBH is the #5 importer of Furosemide from India with $2.0M in import value and 64 verified shipments. SALUTAS PHARMA GMBH holds a 2.9% market share in Furosemide imports based in GERMANY. The company sources from 1 verified supplier across 26 formulations shipped to 1 country. Overall, SALUTAS PHARMA GMBH imports 3 pharmaceutical products worth $5.3M across 2 therapeutic categories.
SALUTAS PHARMA GMBH — Furosemide Import Profile: Suppliers, Formulations & Sources
Who Actually Supplies Furosemide to SALUTAS PHARMA GMBH?
Verified from 64 customs shipment records
| Supplier | Value | Shipments | % Share |
|---|---|---|---|
| SANDOZ PRIVATE LIMITED | $2.0M | 64 | 100.0% |
SALUTAS PHARMA GMBH sources Furosemide from 1 verified Indian supplier based on 64 customs records. The primary supplier is SANDOZ PRIVATE LIMITED accounting for 100.0% of imports.
How Does SALUTAS PHARMA GMBH Compare to Nearest Furosemide Importers?
Buyers ranked immediately above and below #5 by import value
| # | Buyer | Country | Import Value | Shipments | Avg/Shipment |
|---|---|---|---|---|---|
| 4 | RISING PHARMA HOLDINGS INC,., | UNITED STATES | $3.6M | 369 | $9.6K |
| 1 | BAXTER HEALTHCARE CORPORATION | UNITED STATES | $3.1M | 62 | $50.0K |
| 5 | SALUTAS PHARMA GMBH ★ | GERMANY | $2.1M | 64 | $32.2K |
| 7 | VIATRIS SANTE | FRANCE | $1.6M | 33 | $47.9K |
| 9 | AVET PHARMACEUTICALS INC. | UNITED STATES | $1.5M | 35 | $42.0K |
SALUTAS PHARMA GMBH ranks #5 among 778 Furosemide importers from India. Average shipment value of $32.2K compared to the market average of $39.5K. The closest competitors by value are RISING PHARMA HOLDINGS INC,., and BAXTER HEALTHCARE CORPORATION.
Where Does SALUTAS PHARMA GMBH Import Furosemide To?
Destination countries from 64 verified shipments
| Country | Value | Shipments | Share |
|---|---|---|---|
| GERMANY | $2.0M | 64 | 100.0% |
SALUTAS PHARMA GMBH imports Furosemide to 1 country. The primary destination is GERMANY receiving 100.0% of shipments worth $2.0M.
What Furosemide Formulations Does SALUTAS PHARMA GMBH Import?
| Formulation | Value | Shipments |
|---|---|---|
| FUROSEMIDE TAB 40MG IN91 SH EU 02 MATERI | $438.2K | 10 |
| FUROSEMIDE TAB 40MG IN91 SH EU 02 MATERIAL NO - 42024057 | $254.6K | 7 |
| MATERIAL NO - 42024057 FUROSEMIDE TAB 40MG IN91 SH EU 02 | $227.0K | 6 |
| FUROSEMIDE TAB 125MG IN91 SH EU 01 MATER | $158.8K | 6 |
| FUROSEMIDE TAB 500MG IN91 SH EU 01 MATER | $150.0K | 3 |
| Material No. - 42024057 FUROSEMIDE TAB 40MG IN91 SH EU 02 | $85.4K | 2 |
| Material No. - 42024057, FUROSEMIDE TAB | $85.2K | 2 |
| FUROSEMIDE TAB 250MG IN91 SH EU 01 MATER | $76.2K | 3 |
| MATERIAL NO. 42024057 FUROSEMIDE TAB 40MG IN91 SH EU 02 | $64.9K | 6 |
| MATERIAL NO - 42024054 FUROSEMIDE TAB 500MG IN91 SH EU 01 | $50.0K | 1 |
SALUTAS PHARMA GMBH imports 26 distinct Furosemide formulations from India. The top formulation is FUROSEMIDE TAB 40MG IN91 SH EU 02 MATERI with 10 shipments worth $438.2K.
Regulatory Requirements: Importing Furosemide into Germany
What SALUTAS PHARMA GMBH and other importers must comply with to import Furosemide from India
Regulatory Authority
Federal Institute for Drugs and Medical Devices (BfArM) / European Medicines Agency (EMA) (BfArM/EMA)
Approval Process for Generic Furosemide
Marketing Authorisation Application (MAA) under EU Directive 2001/83/EC. Decentralized or Mutual Recognition Procedure for generics. Requires CTD Module 1–5 dossier.
Typical timeline: 12–18 months via Decentralized Procedure
GMP Requirements
EU GMP (EudraLex Vol. 4) compliance; GMP certificate issued by competent authority; WHO Prequalification accepted as supporting evidence
Import Licence & Documentation
Wholesale Distribution Authorisation (WDA) and Manufacturing/Import Authorisation (MIA) required for importer. Qualified Person (QP) must certify each batch.
Labeling & Packaging
EU labeling per Directive 2001/83/EC; German language patient leaflet (PIL) mandatory; serialization under EU Falsified Medicines Directive (FMD)
Note: EU FMD serialization and tamper-evident packaging mandatory since February 2019. Indian API/FDF manufacturers must hold EU GMP certificate.
Regulatory information is provided for general reference based on publicly available BfArM/EMA guidelines for pharmaceutical imports. Requirements may vary by specific drug formulation, dosage form, and therapeutic classification. Importers should consult directly with BfArM/EMA or qualified regulatory affairs professionals for case-specific guidance.
Who Are the Top Buyers of Furosemide from India and How Much Does SALUTAS PHARMA GMBH Import?
India exported $30.7M worth of Furosemide through 4,657 shipments from 333 suppliers to 150 countries, serving 778 buyers globally. SALUTAS PHARMA GMBH imports $2.0M of this total, accounting for 2.9% of India's Furosemide exports with 64 shipments from GERMANY. This is verified from 64 customs shipment records covering 26 distinct formulations.
What Is the Average Order Value for SALUTAS PHARMA GMBH's Furosemide Imports?
SALUTAS PHARMA GMBH's average Furosemide order value is $31.0K per consignment, based on 64 shipments totaling $2.0M. SALUTAS PHARMA GMBH is based in GERMANY and ranks #5 among all Furosemide importers from India by value. The company sources from 1 verified supplier in India.
Who Supplies Furosemide to SALUTAS PHARMA GMBH?
SALUTAS PHARMA GMBH sources Furosemide from 1 verified Indian supplier: SANDOZ PRIVATE LIMITED ($2.0M, 100.0%). This is based on 64 customs records.
How Does SALUTAS PHARMA GMBH Compare to Other Furosemide Importers?
SALUTAS PHARMA GMBH ranks #5 among 778 Furosemide importers from India with a 2.9% market share. The top 3 importers are RISING PHARMA HOLDINGS, INC. ($6.3M), RISING PHARMA HOLDINGS INC ($4.2M), RISING PHARMA HOLDINGS INC,., ($3.6M). SALUTAS PHARMA GMBH processed 64 shipments from GERMANY.
About SALUTAS PHARMA GMBH
SALUTAS PHARMA GMBH imports 3 products worth $5.3M. Beyond Furosemide, top products include Fluticasone, Salmeterol. View the complete SALUTAS PHARMA GMBH profile for full portfolio analysis.
Market Intelligence
Latest developments and market context
Detailed market intelligence for Furosemide — including regulatory updates, trade policy changes, and competitive landscape analysis — will be available in an upcoming update. This section will feature AI-researched insights from verified industry sources, government notifications, and market reports.
Official References & Regulatory Resources
- European Medicines Agency
- WHO Essential Medicines
- Invest India — Pharma Sector
- India Trade Statistics (DGFT)
Verify import regulations and drug registration requirements with the agencies above.
Research Methodology & Data Transparency
Suresh Sormare
Verified AuthorPharmaceutical Export-Import Analyst & Trade Intelligence Expert
Suresh Sormare is a pharmaceutical export-import analyst with deep expertise in Indian Customs (DGFT) data, HS code classification, and global pharmaceutical supply chains. His analysis covers 10M+ shipment records across 150+ countries and is used by manufacturers, procurement agencies, and trade consultants worldwide. Suresh specializes in identifying verified suppliers and buyers from customs records, mapping bilateral pharmaceutical trade corridors, analyzing tariff structures and regulatory frameworks across 170+ destination markets, and benchmarking competitive positioning for finished pharmaceutical formulations. His methodology combines granular customs transaction data with regulatory intelligence from FDA, EMA, WHO, CDSCO, and 40+ national drug authorities to deliver actionable trade insights for the pharmaceutical formulations sector.
linkedin.com/in/sureshsormarePrimary Data Source
All trade data is sourced from Indian Customs (DGFT) official shipping bill records — the authoritative government database for India's pharmaceutical trade. Each verified record contains exporter name, consignee (buyer) name, detailed product description, quantity, declared FOB value (USD), port of loading, destination country, and shipment date.
Analysis Methodology
- 1.Product Matching: Furosemide shipments identified using fuzzy matching on DGFT product description fields, validated against Indian Pharmacopoeia nomenclature and HS code classification.
- 2.Buyer Identification: SALUTAS PHARMA GMBH matched across shipments using first-3-word normalization of the consignee field, accounting for company name formatting variations.
- 3.Statistical Normalization: Shipment values are statistically normalized to ensure accurate market share representation. This removes the impact of unusually large one-off transactions that could distort buyer rankings.
- 4.Market Share: Calculated as SALUTAS PHARMA GMBH's capped import value divided by total capped export value for Furosemide across all Indian exporters.
- 5.Verified Records: This page is backed by 64 individual customs records matching SALUTAS PHARMA GMBH importing Furosemide, covering 26 formulations from 1 verified supplier.
Government-Sourced Data
Official DGFT customs records
Transparent Methodology
Calculations fully disclosed above
Global Coverage
Exports to 150+ countries, 778+ buyers
Expert-Reviewed
Analyzed by pharmaceutical trade specialists
Get Furosemide Import Data for SALUTAS PHARMA GMBH
Access order-level details, pricing data, supplier connections, and competitive analysis for SALUTAS PHARMA GMBH's Furosemide imports. TransData Nexus provides verified Indian Customs (DGFT) data trusted by pharmaceutical trade professionals worldwide.
SALUTAS PHARMA GMBH
Full Company Profile →
3 products · $5.3M total trade · 2 categories
SALUTAS PHARMA GMBH × Furosemide
Verified from customs records
Company Overview
Top Products by SALUTAS PHARMA GMBH
Related Analysis
Need Detailed Import Data?
Access shipment-level records, supplier contacts, and formulation details for SALUTAS PHARMA GMBH.
Request DemoView Pricing →Data Source
Trade data sourced from Indian Customs (DGFT) export shipment records. Values represent FOB export value in USD. Market share calculated relative to total Indian pharmaceutical exports for Furosemide. For current order-level data, contact TransData Nexus.